MXRA5 Is a Novel Immune-Related Biomarker That Predicts Poor Prognosis in Glioma

Table 2

Correlation between the MXRA5 expression and the clinicopathologic characteristics of glioma patients in the CGGA dataset.

Variable	MXRA5 expression		value
	Low ()	High ()
Age			<0.001
≥45	42	80
<45	105	69
Sex			0.125
Male	82	95
Female	67	54
WHO grade			<0.001
GBM	40	83
LGG	109	66
IDH			<0.001
Mutation	93	42
Wild type	56	107
MGMT promoter			0.118
Unmethylated	89	97
Methylated	57	42
Radiotherapy			0.156
Untreated	19	27
Treated	125	112
Chemotherapy			0.965
Untreated	74	70
Treated	68	65

GBM: glioblastoma multiforme; LGG: lower-grade glioma; IDH: isocitrate dehydrogenase; MGMT: methylguanine methyltransferase.